Measurement of the total antioxidant potential in chronic obstructive pulmonary diseases with a novel automated method.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Saudi Medical Journal

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 17768456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers.

  2015cited by this paper
• Comparison of arterial and venous blood gases analysis in patients with exacerbation of chronic obstructive pulmonary disease.

  2007cited by this paper
• Patients adherence to treatment and knowledge about chronic obstructive pulmonary disease.

  2006cited by this paper
• Predictors of long-term survival in patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• The relationship between potency of oxidative stress and severity of dilated cardiomyopathy.

  2005cited by this paper
• A novel automated method to measure total antioxidant response against potent free radical reactions.

  2004cited by this paper
• ROS in the local and systemic pathogenesis of COPD.

  2003cited by this paper
• A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.

  2003cited by this paper
• Systemic effects of chronic obstructive pulmonary disease

  2003cited by this paper
• Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma

  2002cited by this paper
• Assessment of Antioxidant Activity by Using Different In Vitro Methods

  2002cited by this paper
• Systemic effects of chronic obstructive pulmonary disease.

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• Oxidants/antioxidants and COPD.

  2000cited by this paper
• In vivo total antioxidant capacity: comparison of different analytical methods.

  1999cited by this paper
• Comparison of different analytical methods for assessing total antioxidant capacity of human serum.

  1998cited by this paper
• Plasma 3-nitrotyrosine in cigarette smokers.

  1997cited by this paper
• Chronic obstructive pulmonary disease from science to the clinic: the role of glutathione in oxidant-antioxidant balance.

  1997cited by this paper
• Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group.

  1997cited by this paper
• Systemic oxidative stress in asthma, COPD, and smokers.

  1996cited by this paper
• Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

  1996cited by this paper
• Role of oxidants/antioxidants in smoking-induced lung diseases.

  1996cited by this paper
• Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers.

  1995cited by this paper
• Nitric oxide and airway disease.

  1995cited by this paper
• Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

  1994cited by this paper
• Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion.

  1994cited by this paper
• Cigarette Smoke Oxidation of Human Plasma Constituents a

  1993cited by this paper
• Cigarette Smoke‐Mediated Oxidant Stress, Phagocytes, Vitamin C, Vitamin E, and Tissue Injury a

  1993cited by this paper
• Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation.

  1992cited by this paper
• Effects of smoking and vitamin E on blood antioxidant status.

  1991cited by this paper
• Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients.

  1990cited by this paper
• Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay.

  1989cited by this paper
• Lower levels of vitamin C and carotenes in plasma of cigarette smokers.

  1986cited by this paper
• Free radicals in biology and medicine

  1985cited by this paper
• Leucocyte ascorbic acid in abnormal leucocyte states.

  1976cited by this paper
• Leucocyte ascorbic acid in abnormal leucocyte states.

  1976cited by this paper

• Corneal and lens clarity in patients with chronic obstructive pulmonary disease.

  2020cites this paper
• Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review

  2016cites this paper
• The effect of bronchoscopy on oxidative and antioxidative status

  2014cites this paper
• Smoke decreases reversible oxidations S-glutathionylation and S-nitrosylation in mice

  2012cites this paper
• Prolidase activity dysregulation and its correlation with oxidative–antioxidative status in chronic obstructive pulmonary disease

  2011cites this paper
• EVALUATION OF THIOL COMPOUNDS AND LIPID PEROXIDATIVE PRODUCTS IN PLASMA OF PATIENTS WITH COPD

  2010cites this paper
• TOTAL ANTIOXIDANT CAPACITY OF PLASMA DETERMINED AS FERROUS REDUCING ABILITY OF PLASMA IN PATIENTS WITH COPD.

  2010cites this paper
• Turkish version of the functional performance inventory used on patients with chronic obstructive pulmonary disease.

  2009cites this paper